Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Chemical Profiles for Infectious Diarrhea Diagnose Diseases

By HospiMedica staff writers
Posted on 12 Mar 2007
Smells from healthy feces and people with infectious diarrhea differ significantly in their chemical composition and could be used to diagnose quickly diseases such as Clostridium difficile. More...


A study, published online in the February 2007 edition of the online journal FASEB, is the result of a joint collaboration between Dr. Chris Probert, Consultant and Reader in gastroenterology at Bristol University (Bristol, UK) and Professor Norman Ratcliffe at the University of the West of England (Bristol, UK). The study will appear in the June 2007 issue of the printed journal.

For a long time it has been known that stools have distinctive and different odors if there is an infection. What the scientists have done is to take this 'knowledge' a step further by analyzing the odor of healthy donors and patients with gastrointestinal disease to see if precise chemical profiles can be established. The scientists compared feces of healthy donors together with patients with ulcerative colitis, C jejuni, and C difficile and found that the chemical composition of each was significantly different.

Dr Chris Probert said, The discovery of chemical profiles is a major step forward in the diagnosis and treatment of people with gastrointestinal disease. Early treatment of C difficile means patients have a much better chance of survival and fewer complications. However, at present the average length of time taken to diagnose the condition is eight days.

Two of the most common types of infectious diarrhoea are Campylobacter jejuni and C difficile. Although less well known than the methicillin-resistant Staphylococcus aureus (MRSA), C difficile is just as serious, and affects more than 50,000 people each year in England and Wales at a cost to the National Health Service (NHS) of around UK£60 million.

Dr Chris Probert added, There is a huge potential for a rapid diagnosis device in the UK, 30,000 samples are tested in Bristol alone each year. However, the device could be adapted for use in developing countries where 7,000 children die as a result of diarrhea every day. Our next aim is to produce a prototype device capable of diagnosing at any healthcare setting.

Professor Norman Ratcliffe, from the University of the West of England, added, There are numerous different kinds of infection that cause diarrhoea and a speedy diagnosis would lead to more appropriate use of antibiotics. A rapid diagnosis device has the potential to save lives and reduce the cost burden to the National Health Service [NHS; UK]. Early isolation of infectious patients would reduce hospital outbreaks leading to fewer ward/hospital closures.


Related Links:
Bristol University
University of the West of England

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.